Deutsche Bank Initiates AbbVie With Buy

Analysts at Deutsche Bank initiated coverage on shares of AbbVie

with a Buy rating. The target price for AbbVie is set to $80. AbbVie shares have jumped 31.36% over the past 52 weeks, while the S&P 500 index has gained 13.41% in the same period. AbbVie's shares fell 0.20% to close at $63.63 yesterday.